Thomas Kosasa Increases Stake in OneMedNet Corporation
Thomas Kosasa purchased 158,730 shares of OneMedNet Corporation, showcasing ongoing insider interest.
Key Points
- Thomas Kosasa bought 158,730 shares of OneMedNet Corporation at $0.63 each on June 12, 2026.
- OneMedNet trades on NasdaqCM with a market cap of $29.6 million, a beta of 1.122, and a 52-week range of $0.31 to $4.22.
- Other investors like Exencial Wealth Advisors and Vanguard have made significant moves in OneMedNet's stock.
Thomas Kosasa has increased his stake in OneMedNet Corporation, purchasing 158,730 shares at an average price of $0.63 on June 12, 2026. This transaction was not planned in advance, indicating a strategic decision to increase his holdings in the healthcare software company.
What Changed in Thomas Kosasa's OneMedNet Position
Kosasa's latest purchase adds to his previous acquisitions of OneMedNet shares, reflecting his ongoing confidence in the company's prospects. With this latest buy, Kosasa continues to build his position in the company, which specializes in digital medical image management and exchange solutions.
Other Institutional Activity in OneMedNet
Exencial Wealth Advisors, LLC significantly increased its holdings in OneMedNet by 4,732,698 shares, ending with 8,377,559 shares valued at about $7.12 million. Vanguard Capital Management LLC started a new position with 1,115,565 shares valued at approximately $948,230. Geode Capital Management, LLC also boosted its stake by 41,802 shares, bringing its total to 338,528 shares worth $287,782. Meanwhile, Vanguard Fiduciary Trust Co and Citigroup Inc initiated new positions with 136,613 and 135,445 shares respectively.
OneMedNet Corporation Stock Snapshot
Shares of NasdaqCM:ONMD recently traded around $0.54. OneMedNet Corporation has a market capitalization of approximately $29.6 million and a beta of 1.122, indicating its volatility relative to the broader market. The stock's 52-week range spans from $0.31 to $4.22, with a 50-day moving average of $0.88 and a 200-day moving average of $1.15. The company's current ratio stands at 0.273, while its quick ratio is 0.174, suggesting potential liquidity constraints.
Recent Earnings
OneMedNet reported revenues of $1.32 million, though experiencing a revenue decline of 29.9%. The company is not currently profitable, with an EPS of -$0.04 and a net margin of -254.3%. This indicates ongoing challenges in achieving profitability. The next earnings date has not been provided.
Insider Buying and Selling at OneMedNet Corporation
Thomas Kosasa has been actively purchasing shares, with notable buys on May 18, 2026, and April 23, 2026, at prices of $0.93 and $0.89 respectively. Additionally, Jeffrey Yu, the Chief Medical Officer, acquired 219,429 shares at $0.83 on April 1, 2026, and another 903,614 shares on the same day, reflecting insider confidence in the company's future.
About OneMedNet Corporation
OneMedNet Corporation, headquartered in Eden Prairie, Minnesota, is a healthcare software company offering digital medical image management and sharing solutions. Its products, such as iRWD and BEAM, serve the pharmaceutical, device manufacturing, and healthcare sectors across the Americas, Europe, and the Middle East. Led by CEO Aaron Green, the company employs 22 people.
Bottom Line
Thomas Kosasa's recent purchase of OneMedNet shares highlights his confidence in the company's potential despite its current financial challenges. Investors often track insider transactions like these for insights into company prospects. However, it's important to remember that such filings are backward-looking and may not reflect current positions.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.